The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Through Friday, with the latest quarterly results in from more than three-fifths of the S&P 500, 77% have turned in earnings per share higher than analysts expected, according to FactSet.

Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...

Operator Hello and welcome to McDonald's fourth quarter 2024 investor conference call. At the request of McDonald's ...

(NASDAQ: MNDY), the multi-product platform that runs all core aspects of work, today reported financial results for its fourth quarter and ...

McDonald's Corporation (NYSE:MCD) reported its fourth-quarter and full-year earnings for 2024, revealing a slight miss in ...

Q4 2024 Earnings Conference Call highlights strong financial results, strategic partnerships, and growth outlook for 2025.